據ICIS-MRC網站5月11日莫斯科報道，據烴加工網信息顯示，殼牌催化劑與技術公司（Shell Catalysts&Technologies即SC&T）和Arbios Biotech（Licella與Canfor的合資企業）結成了一個新的全球聯盟，旨在利用SC&T的升級技術能力，追求低碳強度、以循環經濟為重點的生物煉制。
Arbios Biotech成立的目的是將Licella的Cat HTR平臺商業化，這是一種全球領先的水熱液化（HTL）技術，用于世界各地，特別是北美、南美和歐洲各種形式的木材和消費后生物質。Cat-HTR使用近超臨界水或超臨界水來制造高質量的生物原油，這是一種可再生和可持續的循環經濟生物油。
Arbios Biotech和SC&T之間的這一聯盟預計，殼牌公司的升級裝置將與商業Cat HTR工廠協同工作，這些工廠位于消費后生物質原料來源聚集區附近。通過將SC&T的升級裝置與Cat-HTR工廠連接起來，Arbios Biotech公司將有能力在一個連續、高效的過程中將生物原油升級為成品。
郝芬 譯自 ICIS-MRC
原文如下：
Shell forms alliance with Arbios Biotech in pursuit of a low-carbon intensity, circular-economy focused biorefinery
Shell Catalysts & Technologies and Arbios Biotech, a joint venture between Licella and Canfor, have formed a new global alliance aimed at utilizing SC&T’s upgrading technology capability in the pursuit of a low-carbon intensity, circular-economy focused biorefinery, according to Hydrocarbonprocessing.
Arbios Biotech was formed to commercialise Licella’s Cat-HTR platform, a globally leading hydrothermal liquefaction (HTL) technology, for various forms of wood and post-consumer biomass around the world, particularly in North America, South America and Europe. The Cat-HTR uses near or at supercritical water to create high-quality biocrude, a renewable and sustainable bio oil for the circular economy.
This alliance between Arbios Biotech and SC&T anticipates that Shell upgrader units will work in concert with commercial Cat-HTR plants, strategically located near aggregated post-consumer biomass feedstock sources. By linking SC&T upgrader units with Cat-HTR plants, Arbios Biotech would have the capability to upgrade biocrude to finished products in one continuous, efficient process.
免責聲明：本網轉載自其它媒體的文章，目的在于弘揚石化精神，傳遞更多石化信息，并不代表本網贊同其觀點和對其真實性負責，在此我們謹向原作者和原媒體致以敬意。如果您認為本站文章侵犯了您的版權，請與我們聯系，我們將第一時間刪除。
